Tobii AB (publ) uses its right to early redemption of its outstanding 2019/2022 bonds

Report this content

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S PERSON (U.S. PERSON, AS DEFINED IN THE REGULATION S OF THE UNITED STATES SECURITES ACT OF 1933, IN ITS CURRENT WORDING) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND THE UNITED KINGDOM) MAY BE RESTRICTED BY LAW.

Tobii AB (publ) (the “Issuer”) has previously issued secured floating rate bonds with final redemption date on 21 February 2022, ISIN SE0012230076 (the “Bonds”). The Issuer has formally used its right to early voluntary redemption of the Bonds (the “Early Redemption”) in accordance with Clause 11.3 (Early voluntary redemption by the Issuer (call option)) of the terms and conditions for the Bonds and the Bonds will be redeemed early at a price per Bond equal to 100.575 per cent of the nominal amount per Bond plus any accrued and unpaid interest to, and including, the redemption date which is expected to be on 21 October 2021.

The redemption amount, including accrued and unpaid interest, will be paid to each person who is registered as owner of Bonds in the debt register maintained by Euroclear Sweden at end of business on the record date, being 14 October 2021. In connection with the Early Redemption, the Bonds will be delisted from Nasdaq Stockholm and the last trading day is on 12 October 2021.

Contact

Henrik Mawby, Head of Investor Relations, Tobii Group, phone: +46 (0)72 219 82 15, email: henrik.mawby@tobii.com

About Tobii

Tobii is the global leader in eye tracking. Our mission is to improve the world with technology that understands human attention and intent. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye tracking equipment and services used today by more than 3,500 companies and 2,500 research institutions, including 98 of the world’s 100 highest ranked universities. Tobii Tech supplies eye tracking technology for integration into consumer electronics and other products such as personal computers, virtual reality headsets, healthcare applications, automotive DMS and more. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 1,000 employees. For more information:www.tobii.com.